Education
About Us
Working with TipRanks
Follow Us
MediPharm Labs (MEDIF)
OTHER OTC:MEDIF
MEDIF Stock Chart & Stats
$0.05
$0.00(0.00%)
At close: 4:00 PM EST
$0.05
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.04 - $0.09
Previous CloseN/A
Volume94.37K
Average Volume (3M)283.50K
Market Cap
$22.97M
Enterprise Value$21.40M
Total Cash (Recent Filing)$10.58M
Total Debt (Recent Filing)$423.00K
Price to Earnings (P/E)―
Beta-0.03
Next Earnings
Apr 01, 2026Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding420,755,000
10 Day Avg. Volume139,467
30 Day Avg. Volume283,499
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)0.57
Price to Sales (P/S)0.58
P/FCF Ratio-4.88
Enterprise Value/Market Cap0.93
Enterprise Value/Revenue0.46
Enterprise Value/Gross Profit1.59
Enterprise Value/Ebitda-3.49
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
MediPharm Labs News
MEDIF FAQ
What was MediPharm Labs’s price range in the past 12 months?
MediPharm Labs lowest stock price was $0.04 and its highest was $0.09 in the past 12 months.
What is MediPharm Labs’s market cap?
MediPharm Labs’s market cap is $22.97M.
When is MediPharm Labs’s upcoming earnings report date?
MediPharm Labs’s upcoming earnings report date is Apr 01, 2026 which is in 98 days.
How were MediPharm Labs’s earnings last quarter?
MediPharm Labs released its earnings results on Nov 13, 2025. The company reported -$0.007 earnings per share for the quarter, missing the consensus estimate of -$0.002 by -$0.005.
Is MediPharm Labs overvalued?
According to Wall Street analysts MediPharm Labs’s price is currently Overvalued.
Does MediPharm Labs pay dividends?
MediPharm Labs does not currently pay dividends.
What is MediPharm Labs’s EPS estimate?
MediPharm Labs’s EPS estimate is 0.
How many shares outstanding does MediPharm Labs have?
MediPharm Labs has 420,755,000 shares outstanding.
What happened to MediPharm Labs’s price movement after its last earnings report?
MediPharm Labs reported an EPS of -$0.007 in its last earnings report, missing expectations of -$0.002. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of MediPharm Labs?
Currently, no hedge funds are holding shares in MEDIF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
MediPharm Labs
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. It formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. The company also provides GMP flower sourcing, packaging, and distribution services. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.
MEDIF Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects positive trends in financial performance, especially with record gross profit and strong international growth. However, it is overshadowed by challenges in the Canadian market and significant concerns over activist shareholder issues. This creates a mixed outlook, with strong operational performance but potential strategic risks.View all MEDIF earnings summariesTechnical Analysis
iAnthus Capital Holdings
―
Ayr Wellness
―
Decibel Cannabis Company
―
Vext Science
―
Avicanna
―
Ownership Overview
Options Prices
Currently, No data available
---